Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance Fulltext Access 8 Pages 2006
Childhood acute myelogenous leukaemia: Association between PRAME, apoptosis- and MDR-related gene expression Fulltext Access 8 Pages 2006
Better quality of life among 10–15 year survivors of Hodgkin’s lymphoma compared to 5–9 year survivors: A population-based study Fulltext Access 8 Pages 2006
Treatment and survival for non-Hodgkin's lymphoma: Influence of histological subtype, age, and other factors in a population-based study (1999-2001) Fulltext Access 8 Pages 2006
Reduced mortality for women with mammography-detected breast cancer in east Denmark and south Sweden Fulltext Access 8 Pages 2006
Post-treatment intellectual functioning in children treated for acute lymphoblastic leukaemia (ALL) with chemotherapy-only: A prospective, sibling-controlled study Fulltext Access 8 Pages 2006
Role of radiotherapy and chemotherapy in the risk of secondary leukaemia after a solid tumour in childhood Fulltext Access 8 Pages 2006
TuBaFrost 2: Standardising tissue collection and quality control procedures for a European virtual frozen tissue bank network Fulltext Access 8 Pages 2006
The effect of hyperbaric oxygen therapy on tumour growth in a mouse model of colorectal cancer liver metastases Fulltext Access 8 Pages 2006
Generalisability of survival estimates for patients with breast cancer – A comparison across two population-based series Fulltext Access 8 Pages 2006
Clinical heart failure in a cohort of children treated with anthracyclines: A long-term follow-up study Fulltext Access 8 Pages 2006
Continuous versus intermittent tamoxifen versus intermittent/alternated tamoxifen and medroxyprogesterone acetate as first line endocrine treatment in advanced breast cancer: An EORTC phase III study (10863) Fulltext Access 8 Pages 2006
Capecitabine plus oxaliplatin (xelox) versus protracted 5-fluorouracil venous infusion plus oxaliplatin (pvifox) as first-line treatment in advanced colorectal cancer: A GOAM phase II randomised study (FOCA trial) Fulltext Access 8 Pages 2006
Pyrazolo[3,4-d]pyrimidines c-Src inhibitors reduce epidermal growth factor-induced migration in prostate cancer cells Fulltext Access 8 Pages 2006
Surgical treatment of ovarian cancer in different hospital categories – A prospective nation-wide study in Finland Fulltext Access 8 Pages 2006
Randomized evidence on chemotherapy and hormonal therapy regimens for advanced endometrial cancer: An overview of survival data Fulltext Access 8 Pages 2006
Is nuclear factor kappa-B the missing link between inflammation, cancer and alteration in hepatic drug metabolism in patients with cancer? Fulltext Access 8 Pages 2006
Cancer in children and adolescents in Europe: Developments over 20 years and future challenges Fulltext Access 8 Pages 2006
Mutational analysis of β-catenin and the RAS-RAF signalling pathway in early flat-type colorectal tumours Fulltext Access 8 Pages 2006
Human neutrophil peptides 1, 2 and 3 are biochemical markers for metastatic colorectal cancer Fulltext Access 8 Pages 2006
Thimet oligopeptidase (EC 3.4.24.15) activates CPI-0004Na, an extracellularly tumour-activated prodrug of doxorubicin Fulltext Access 8 Pages 2006
Unilateral retinoblastoma, lack of familial history and older age does not exclude germline RB1 gene mutation Fulltext Access 8 Pages 2006
Diagnostic 'errors' in anatomical pathology: relevance to Australian laboratories Fulltext Access 8 Pages 2006
Clinical trials design and treatment tailoring: General principles applied to breast cancer research Fulltext Access 8 Pages 2006
Hypertensive patients with carotid artery plaque exhibit increased platelet aggregability Fulltext Access 8 Pages 2006
Arterial antithrombotic effects of aspirin, heparin, enoxaparin and clopidogrel alone, or in combination, in the rat Fulltext Access 8 Pages 2006
Prognostic significance of combined expression of MUC1 and adhesion molecules in advanced gastric cancer Fulltext Access 8 Pages 2006
Phase I clinical and pharmacological evaluation of the multi-tyrosine kinase inhibitor SU006668 by chronic oral dosing Fulltext Access 8 Pages 2006
Genotyping and phenotyping cytochrome P450: Perspectives for cancer treatment Fulltext Access 8 Pages 2006
Expression of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) as a prognostic indicator in gastric cancer Fulltext Access 8 Pages 2006
Social determinants of access to reference care centres for patients with colorectal cancer – A multilevel analysis Fulltext Access 8 Pages 2006
Does a patient’s self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer? Fulltext Access 8 Pages 2006
Budding invasive margin and prognosis in colorectal cancer – no direct association with β-catenin expression Fulltext Access 8 Pages 2006
The role of mannose-binding lectin (MBL) in paediatric oncology patients with febrile neutropenia Fulltext Access 8 Pages 2006
Efficacy and tolerability of chemotherapy in elderly patients with advanced oesophago-gastric cancer: A pooled analysis of three clinical trials Fulltext Access 8 Pages 2006
Assessing health-related quality of life in palliative care: Comparing patient and physician assessments Fulltext Access 8 Pages 2006
Adenocarcinoma of the oesophagus and gastric cardia: Male preponderance in association with obesity Fulltext Access 8 Pages 2006
BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives Fulltext Access 8 Pages 2006
Updating long-term childhood cancer survival trend with period and mixed analysis: Good news from population-based estimates in Italy Fulltext Access 8 Pages 2006
Characterisation of a novel high-purity, double virus inactivated von Willebrand Factor and Factor VIII concentrate (Wilate®) Fulltext Access 8 Pages 2006
Modulation of cell growth and cisplatin sensitivity by membrane γ-glutamyltransferase in melanoma cells Fulltext Access 8 Pages 2006
5-Aminosalicylic acid enhances anchorage-independent colorectal cancer cell death Fulltext Access 8 Pages 2006
Physical activity, obesity, and risk of colon and rectal cancer in a cohort of Swedish men Fulltext Access 8 Pages 2006
Mortality from cancer among ethnic German immigrants from the Former Soviet Union, in Germany Fulltext Access 8 Pages 2006
To predict progression-free survival and overall survival in metastatic renal cancer treated with sorafenib: Pilot study using dynamic contrast-enhanced Doppler ultrasound Fulltext Access 8 Pages 2006
A genomic explanation connecting “Mediterranean diet”, olive oil and cancer: Oleic acid, the main monounsaturated Fatty acid of olive oil, induces formation of inhibitory “PEA3 transcription factor-PEA3 DNA binding site” complexes at the Her-2/neu (erbB-2 Fulltext Access 8 Pages 2006
Quality of life and persisting symptoms after oesophageal cancer surgery Fulltext Access 8 Pages 2006
Docetaxel and cisplatin as induction chemotherapy in patients with pathologically-proven stage IIIA N2 non-small cell lung cancer: a phase II study of the European organization for research and treatment of cancer (EORTC 08984) Fulltext Access 8 Pages 2006
Quality assurance of thoracic radiotherapy in EORTC 08941: A randomised trial of surgery versus thoracic radiotherapy in patients with stage IIIA non-small-cell lung cancer (NSCLC) after response to induction chemotherapy Fulltext Access 8 Pages 2006
DNA hypomethylation therapy for hemoglobin disorders: Molecular mechanisms and clinical applications Fulltext Access 8 Pages 2006
Differential expression of the components of the plasminogen activating system in human thyroid tumour derived cell lines and papillary carcinomas Fulltext Access 8 Pages 2006
Comparative molecular characterization of gene segment 11-derived NSP6 from lamb rotavirus LLR strain used as a human vaccine in China Fulltext Access 8 Pages 2006
Effect of relevant culture parameters on Pertussis Toxin expression by Bordetella pertussis Fulltext Access 8 Pages 2006
Comparative analysis of stereotactic radiosurgery treatment plans in brain cases with one and two tumour changes using conformity indices Fulltext Access 8 Pages 2006
Postoperative adjuvant chemoradiotherapy in patients with rectal cancer. Prognostic factors for locoregional control and survival Fulltext Access 8 Pages 2006
Radiotherapy in combination with simultaneous intra-arterial chemotherapy (RADPLAT) in patients with advanced head and neck cancer Fulltext Access 8 Pages 2006
Blood transfusion in Europe: basic principles for initial and continuous training in transfusion medicine: an approach to an European harmonisation Fulltext Access 8 Pages 2006
The challenge of understanding ammonium homeostasis and the role of the Rh glycoproteins Fulltext Access 8 Pages 2006
Biological gas channels for NH3 and CO2: evidence that Rh (Rhesus) proteins are CO2 channels Fulltext Access 8 Pages 2006
The ‘metabolon’, CD47, and the ‘phagocytic synapse’: molecular co-localization and species divergence Fulltext Access 8 Pages 2006
Development of a disease-specific quality of life questionnaire module for patients with gastrointestinal neuroendocrine tumours Fulltext Access 8 Pages 2006
Histopathological prognostic factors in medulloblastoma: High expression of survivin is related to unfavourable outcome Fulltext Access 8 Pages 2006
Changes in bone and lipid metabolism in postmenopausal women with early breast cancer after terminating 2-year treatment with exemestane: A randomised, placebo-controlled study Fulltext Access 8 Pages 2006
High inter-observer agreement in immunohistochemical evaluation of HER-2/neu expression in breast cancer: A multicentre GEFPICS study Fulltext Access 8 Pages 2006
Predictive and prognostic markers for the outcome of chemotherapy in advanced colorectal cancer, a retrospective analysis of the phase III randomised CAIRO study Fulltext Access 8 Pages 2006
Clinical significance of Vascular Endothelial Growth Factor-A expression in Ewing’s sarcoma Fulltext Access 8 Pages 2006
Tissue inhibitor of metalloproteinases-1 in the postoperative monitoring of colorectal cancer Fulltext Access 8 Pages 2006
TRF2 inhibition triggers apoptosis and reduces tumourigenicity of human melanoma cells Fulltext Access 8 Pages 2006
A phase I clinical and pharmacokinetic study of paclitaxel and docetaxel given in combination in patients with solid tumours Fulltext Access 8 Pages 2006
Information provision for patients by breast cancer teams about the side-effects of hormone treatments Fulltext Access 8 Pages 2006
Survival in France after childhood acute leukaemia and non-Hodgkin's lymphoma (1990-2000) Fulltext Access 8 Pages 2006
Evaluation of oestrogen and progesterone receptor status in HER-2 positive breast carcinomas and correlation with outcome Fulltext Access 8 Pages 2006
Role of prostaglandin E2 in the invasiveness, growth and protection of cancer cells in malignant pleuritis Fulltext Access 8 Pages 2006
Overexpression of poly(ADP-ribose) polymerase-1 (PARP-1) in the early stage of colorectal carcinogenesis Fulltext Access 8 Pages 2006
Safety and pharmacokinetics of temozolomide using a dose-escalation, metronomic schedule in recurrent paediatric brain tumours Fulltext Access 8 Pages 2006
Toxicity profile of the immunomodulatory thalidomide analogue, lenalidomide: Phase I clinical trial of three dosing schedules in patients with solid malignancies Fulltext Access 8 Pages 2006
Patient-reported assessment of quality care at end of life: Development and validation of Quality Care Questionnaire-End of Life (QCQ-EOL) Fulltext Access 8 Pages 2006
Endothelin-3 production by human rhabdomyosarcoma: A possible new marker with a paracrine role Fulltext Access 8 Pages 2006
Time trends of incidence, mortality, and relative survival of invasive skin melanoma in Lithuania Fulltext Access 8 Pages 2006
Risk-reducing surgery in women with familial susceptibility for breast and/or ovarian cancer Fulltext Access 8 Pages 2006
Chronomodulated chemotherapy for colorectal cancer: Failing the test of time? Fulltext Access 8 Pages 2006
Overexpression of a member of the pentraxin family (PTX3) in human soft tissue liposarcoma Fulltext Access 8 Pages 2006